ASTH — APOLLO MED HLDGS INC

Ownership history in 325 CAPITAL LLC · 14 quarters on record

This page tracks every 13F SEC filing in which 325 CAPITAL LLC reported a position in APOLLO MED HLDGS INC (ASTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

16.7% (2024 Q3)

Avg. % of fund

12.26%

First filed

2022 Q3

Last filed

2025 Q4

Quarters held

14

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	ADDED	1,839,076	+645,123	+54.0%	15.99%	$45.6M	$24.81
2025 Q3	ADDED	1,193,953	+307,037	+34.6%	10.29%	$33.8M	$28.35
2025 Q2	UNCHANGED	886,916	—	0%	8.71%	$22.1M	$24.88
2025 Q1	UNCHANGED	886,916	—	0%	11.39%	$27.5M	$31.01

% of Fund (quarterly) ASTH price (monthly, adj. close)

Other funds also holding ASTH

As of 2025 Q4 — sorted by position size

1492 Capital Management LLC 3Y 7Y 1.59% QSV Equity Investors LLC 1.09% SteelPeak Wealth, LLC 3Y 0.47% Insight Wealth Strategies, LLC 3Y 7Y 0.4% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.38% Shay Capital LLC 3Y 0.31% Capstone Capital Management Ltd 0.28% NorthCrest Asset Manangement, LLC 3Y 0.28% ROYCE & ASSOCIATES LP 3Y 7Y 0.09% SG Capital Management LLC 3Y 7Y 0.08%

← Back to 325 CAPITAL LLC Holdings